Characterization of anti-SARS-CoV-2 monoclonal antibodies focusing on antigen binding, neutralization, and FcγR activation via formation of immune complex

M Tada, M Aoyama, A Ishii-Watabe - MAbs, 2023 - Taylor & Francis
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV− 2) causes coronavirus
disease 2019 (COVID− 19). Antibodies induced by SARS-CoV− 2 infection or vaccination …
被引用次数：3 相关文章

Characterization of anti-SARS-CoV-2 monoclonal antibodies focusing on antigen binding, neutralization, and FcγR activation via formation of immune complex.

M Tada, M Aoyama, A Ishii-Watabe - Mabs, 2023 - europepmc.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV− 2) causes coronavirus
disease 2019 (COVID− 19). Antibodies induced by SARS-CoV− 2 infection or vaccination …
[PDF] scienceopen.com

[PDF][PDF] Characterization of anti-SARS-CoV-2 monoclonal antibodies focusing on antigen binding, neutralization, and FcγR activation via formation of immune complex

M Tada, M Aoyama, A Ishii-Watabe - 2023 - scienceopen.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV− 2) causes coronavirus
disease 2019 (COVID− 19). Antibodies induced by SARS-CoV− 2 infection or vaccination …

Characterization of anti-SARS-CoV-2 monoclonal antibodies focusing on antigen binding, neutralization, and FcγR activation via formation of immune complex

M Tada, M Aoyama, A Ishii-Watabe - mAbs, 2023 - pubmed.ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus
disease 2019 (COVID-19). Antibodies induced by SARS-CoV-2 infection or vaccination play …
[HTML] nih.gov

[HTML][HTML] Characterization of anti-SARS-CoV-2 monoclonal antibodies focusing on antigen binding, neutralization, and FcγR activation via formation of immune …

M Tada, M Aoyama, A Ishii-Watabe - mAbs, 2023 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV− 2) causes coronavirus
disease 2019 (COVID− 19). Antibodies induced by SARS-CoV− 2 infection or vaccination …

Characterization of anti-SARS-CoV-2 monoclonal antibodies focusing on antigen binding, neutralization, and FcγR activation via formation of immune complex.

M Tada, M Aoyama, A Ishii-Watabe - Mabs, 2023 - europepmc.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus
disease 2019 (COVID-19). Antibodies induced by SARS-CoV-2 infection or vaccination play …